BioSpace News Archive

Transparency Market Research has published a new report titled ‘Hyperpigmentation Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global hyperpigmentation disorders treatment market was valued at US$ 3,947.3 Mn in 2017 and is projected to reach US$ 7,225.6 Mn by 2026, expanding at a CAGR of 7.2% during the forecast period from 2018 to 2026.

Transparency Market Research has published a new report titled, “Dementia Associated with Alzheimer’s Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Recombinase polymerase amplification or RPA refers to an isothermal, single tube alternative option to the lab technique of PCR or polymerase chain reaction.

Transparency Market Research has published a new report titled, “Adult Malignant Glioma Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global adult malignant glioma therapeutics market was valued at US$ 1,349.6 Mn in 2017 and is projected to expand at a CAGR of 9.2% from 2018 to 2026.

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization, announces the promotion of Dr. John Mott to Vice President of Development.

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Integumen plc to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in waste water, to provide a real-time alert system to warn of localised COVID-19 outbreaks.

Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medical’s mobile Tablo Hemodialysis System at home since it received FDA clearance on March 31.

The global tyrosine kinase inhibitors market was valued at US$ 18.3 Bn in 2017.

Significant players operating in the global T-cell acute lymphoblastic leukemia market incorporate Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Erytech Pharma, Inc., Sanofi, and Celgene Corporation.

The demand within the global market for scleroderma diagnostics and therapeutics has been rising on account of advancements in the field of rheumatoid treatments, finds Transparency Market Research.